CONNECTION BETWEEN GUT DYSBIOSIS AND GENERALIZED ANXIETY DISORDER: A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6084Keywords:
Generalized Anxiety Disorder, Gut Dysbiosis, Gut Microbiota, Anxiety Disorders, Microbiota–Gut–Brain Axis, PsychobioticsAbstract
Objective: This narrative review aims to summarize current evidence regarding the relationship between gut dysbiosis and Generalized Anxiety Disorder (GAD), with particular emphasis on alterations in gut microbiota composition, proposed biological mechanisms, and potential microbiome-targeted therapeutic strategies.
Methods: A narrative review was conducted using thirteen peer-reviewed publications, including systematic reviews, narrative reviews, mechanistic studies, and clinical investigations examining associations between gut microbiota and anxiety disorders. The selected studies were analyzed to identify recurring microbiome-related findings, proposed mechanisms linking gut dysbiosis and anxiety, and evidence regarding microbiome-based interventions.
Results: The reviewed literature consistently demonstrated significant associations between gut dysbiosis and anxiety disorders. Patients with GAD and related anxiety conditions frequently exhibited reduced microbial diversity, depletion of beneficial short-chain fatty acid-producing bacteria, and increased abundance of potentially pro-inflammatory taxa. Several studies highlighted disturbances in microbial metabolite production, neurotransmitter regulation, immune function, and stress-response pathways. Clinical investigations further revealed alterations in both microbial composition and microbial metabolic activity among individuals with anxiety disorders. Additionally, microbiome-targeted interventions, including probiotics, psychobiotics, and dietary modification, showed potential benefits in reducing anxiety symptoms, although findings remain heterogeneous.
Conclusions: Current evidence supports a meaningful relationship between gut dysbiosis and anxiety disorders. Alterations in gut microbiota may contribute to anxiety pathophysiology through immune, metabolic, endocrine, and neurochemical mechanisms. However, the predominance of cross-sectional studies and methodological heterogeneity limit causal interpretation. Future longitudinal studies and randomized controlled trials are necessary to clarify causal relationships and evaluate the clinical utility of microbiome-based therapeutic interventions in Generalized Anxiety Disorder.
References
Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022). The gut microbiome in depression and potential benefit of prebiotics, probiotics and synbiotics: A systematic review of clinical trials and observational studies. International Journal of Molecular Sciences, 23(9), 4494. https://doi.org/10.3390/ijms23094494
Ataei, P., Kalantari, H., Bodnar, T. S., & Turner, R. J. (2025). The gut–brain connection: Microbes’ influence on mental health and psychological disorders. Frontiers in Microbiomes, 4, 1701608. https://doi.org/10.3389/frmbi.2025.1701608
Butler, M. I., Bastiaanssen, T. F. S., Long-Smith, C., Mörkl, S., Berding, K., Ritz, N. L., Strain, C., Patangia, D., Patel, S., Stanton, C., O’Mahony, S. M., Cryan, J. F., Clarke, G., & Dinan, T. G. (2023). The gut microbiome in social anxiety disorder: Evidence of altered composition and function. Translational Psychiatry, 13, 95. https://doi.org/10.1038/s41398-023-02325-5
Butler, M. I., Kittel-Schneider, S., Wagner-Skacel, J., Mörkl, S., & Clarke, G. (2025). The gut microbiome in anxiety disorders. Current Psychiatry Reports, 27(5), 347–361. https://doi.org/10.1007/s11920-025-01604-w
Jiang, H., Zhang, X., Yu, Z., Zhang, Z., Deng, M., Zhao, J., & Ruan, B. (2018). Altered gut microbiota profile in patients with generalized anxiety disorder. Journal of Psychiatric Research, 104, 130–136. https://doi.org/10.1016/j.jpsychires.2018.07.007
Jiang, M., Kang, L., Wang, Y.-L., Zhou, B., Li, H.-Y., Yan, Q., & Liu, Z.-G. (2024). Mechanisms of microbiota–gut–brain axis communication in anxiety disorders. Frontiers in Neuroscience, 18, 1501134. https://doi.org/10.3389/fnins.2024.1501134
Krupa-Kotara, K., Gwioździk, W., Nandzik, S., & Grajek, M. (2023). The role of microbiota pattern in anxiety and stress disorders—A review of the state of knowledge. Psych, 5(3), 602–618. https://doi.org/10.3390/psych5030038
MacKay, M., Yang, B. H., Dursun, S. M., & Baker, G. B. (2024). The gut-brain axis and the microbiome in anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder. Current Neuropharmacology, 22(5), 866–883. https://doi.org/10.2174/1570159X21666230222092029
Nikel, K., Stojko, M., Smolarczyk, J., & Piegza, M. (2025). The impact of gut microbiota on the development of anxiety symptoms—A narrative review. Nutrients, 17(6), 933. https://doi.org/10.3390/nu17060933
Shaikh, R. G., Dey, A., Singh, V. P., Khandagle, A., Baskaran, M., Naik, S., & Hasan, A. (2025). Understanding the impact of the gut microbiome on mental health: A systematic review. Cureus, 17(1), e78100. https://doi.org/10.7759/cureus.78100
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021). The gut microbiota in anxiety and depression: A systematic review. Clinical Psychology Review, 83, 101943. https://doi.org/10.1016/j.cpr.2020.101943
Spivak, N. M., Haroon, J., Swenson, A., Turnbull, S. A., Dang, N., Ganeles, M., Price, C., Distler, M., Nurmi, E., Lavretsky, H., & Bystritsky, A. (2023). Microbiome in anxiety and other psychiatric disorders. Medical Clinics of North America, 107(1), 73–83. https://doi.org/10.1016/j.mcna.2022.08.010
Yang, B., Wei, J., Ju, P., & Chen, J. (2019). Effects of regulating intestinal microbiota on anxiety symptoms: A systematic review. General Psychiatry, 32(2), e100056. https://doi.org/10.1136/gpsych-2019-100056
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Katarzyna Wites, Piotr Wites, Hubert Łagosz, Patryk Piotrowski, Alicja Włodarczyk, Aleksandra Jabłońska, Magdalena Pyzik, Kinga Ziółkowska, Karolina Markusiewicz, Piotr Bahyrycz
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
